Growth Hormone Research & Evidence Review

Summary

Growth hormone is secreted in pulses from the anterior pituitary and acts largely through hepatic IGF-1. Its decline with age is well documented, but the evidence that raising it in healthy older adults is beneficial is weak, and animal longevity data points in the opposite direction — reduced GH signalling extends lifespan in mice.

Last reviewed 2026-09-01

What it is

Growth hormone (somatotropin) is a 191–amino-acid protein hormone from anterior pituitary somatotrophs, released in pulses with the largest occurring during slow-wave sleep.

Cadaveric GH was used clinically from the 1950s until Creutzfeldt-Jakob transmission ended the practice; recombinant GH followed in 1985. A small 1990 study by Daniel Rudman in the New England Journal of Medicine reported body composition changes in older men and, despite its size and limitations, became the foundation of the anti-ageing GH industry.

Endogenous, regulated by hypothalamic GHRH (stimulatory) and somatostatin (inhibitory), with ghrelin as an additional secretagogue.

GH sits at the centre of a genuine conflict in the literature: it builds tissue in the short term, yet reduced GH signalling is one of the most reproducible lifespan-extending manipulations in mice.

How it works

In plain terms

The pituitary releases growth hormone in bursts, mostly during deep sleep. Most of its growth effects happen indirectly, through IGF-1 made by the liver. The pulsing pattern matters as much as the total amount.

Technical detail

GHRH stimulates and somatostatin inhibits pulsatile GH release; ghrelin acts on GHS-R1a to amplify pulses. GH binds the GH receptor, activating JAK2-STAT5 signalling and driving hepatic IGF-1 production, which mediates most anabolic effects. Direct GH effects include lipolysis in adipose tissue and reduced glucose uptake — GH is diabetogenic at higher exposure. IGF-1 negatively feeds back at hypothalamic and pituitary level. Continuous exposure produces a different biological outcome from pulsatile exposure, which is why GH secretagogues and exogenous GH are not equivalent.

Pathways involved

GHRH / somatostatin / ghrelin regulation of pulsatile release
GHR → JAK2-STAT5 → hepatic IGF-1
Direct lipolytic and anti-insulin effects
IGF-1 negative feedback

Current research

Laboratory research

GHR signalling is thoroughly characterised. Pulsatility-dependent gene expression differences are well demonstrated in hepatocyte models.

Animal research

GHR-knockout (Laron) mice are the longest-lived laboratory mouse strains recorded, and Ames and Snell dwarf mice with GH deficiency also show substantial lifespan extension. Conversely, GH-overexpressing transgenic mice are short-lived. This is among the most reproducible findings in ageing biology.

Human research

GH replacement in diagnosed adult GH deficiency improves body composition, bone density and quality of life. In healthy older adults, a 2007 systematic review found modest lean mass increase and fat mass decrease with no strength or functional benefit, and high rates of oedema, arthralgia, carpal tunnel syndrome and glucose intolerance. Humans with Laron syndrome — GH receptor deficiency — show very low incidence of cancer and diabetes, mirroring the mouse data.

Ongoing research

Interest has shifted toward secretagogues that preserve pulsatility and toward understanding the longevity trade-off.

What is being investigated

GH replacement in diagnosed adult deficiency
Body composition effects in healthy ageing
GH secretagogues and preserved pulsatility
GH/IGF-1 signalling and lifespan in model organisms
Sleep architecture and endogenous GH secretion

These are research directions reported in the literature, not established effects or recommendations.

Risks, limitations and unknowns

Read this section before the rest

Reduced GH signalling extends lifespan in mice — the opposite of what anti-ageing marketing implies
Adverse effects in healthy older adults are common: oedema, joint pain, carpal tunnel syndrome and glucose intolerance
GH is diabetogenic; insulin resistance rises with exposure
Theoretical cancer concerns follow from IGF-1's mitogenic activity; Laron syndrome cohorts show reduced cancer incidence
Distribution for anti-ageing purposes is illegal in the United States and restricted in most jurisdictions

Evidence ratings

Laboratory studies

Strong

Signalling and pulsatility biology well established.

Animal longevity data

Strong

Reduced GH signalling reproducibly extends murine lifespan.

Replacement in deficiency

Strong

Clear benefit in diagnosed adult GH deficiency.

Use in healthy ageing

Limited

Modest body composition change, no functional benefit, frequent adverse effects.

References

[1]GH in healthy elderly — systematic review — PubMed / Annals of Internal Medicine, 2007
[2]GH receptor deficiency and disease incidence — PubMed, 2011
[3]GH/IGF-1 signalling and lifespan — PubMed, 2000–present
Reference links open searches and records on PubMed and ClinicalTrials.gov so that every statement above can be traced to primary literature.

Frequently asked questions

What is growth hormone?+

A 191–amino-acid pituitary hormone released in pulses that drives growth largely through hepatic IGF-1 production.

Does growth hormone reverse ageing?+

No. Reviews in healthy older adults show modest body composition change without functional benefit, and reduced GH signalling extends lifespan in mice.

What was the Rudman study?+

A small 1990 NEJM study reporting body composition changes in 12 older men given GH. It was never intended to support the industry built on it.

Why does deep sleep matter for GH?+

The largest GH pulses occur during slow-wave sleep, so sleep quality is a primary determinant of endogenous secretion.

What is Laron syndrome?+

GH receptor deficiency. Affected individuals are short-statured and show strikingly low rates of cancer and type 2 diabetes.

Are GH secretagogues the same as GH?+

No. Secretagogues stimulate the pituitary's own pulsatile release, which is biologically different from continuous exogenous exposure.

Does GH cause diabetes?+

GH opposes insulin action and raises glucose. Glucose intolerance is a documented adverse effect of GH administration.

Is GH legal for anti-ageing use?+

Distribution for anti-ageing purposes is illegal in the United States and restricted in most other jurisdictions; approved uses are specific medical indications.

Continue your research

IGF-1 research

Testosterone research

Cellular health